Subject: | |
From: | |
Reply To: | |
Date: | Tue, 13 Dec 2011 11:34:38 -0700 |
Content-Type: | text/plain |
Parts/Attachments: |
|
|
*****
To join, leave or search the confocal microscopy listserv, go to:
http://lists.umn.edu/cgi-bin/wa?A0=confocalmicroscopy
*****
If possible, spectral unmixing may help. As a random thought, even if you
don't have a spectral detector, you might be able to ratio a narrowband
filtered signal vs a broader filtered signal to figure out what is Pyrene
and what is NADH. You would only need two detectors.
Craig
On Tue, Dec 13, 2011 at 12:34 AM, Cameron Nowell <
[log in to unmask]> wrote:
> *****
> To join, leave or search the confocal microscopy listserv, go to:
> http://lists.umn.edu/cgi-bin/wa?A0=confocalmicroscopy
> *****
>
> Hi List,
>
> We are trying to image uptake of a Pyrene based dye by some cells using
> two-photon excitation (as we don't have a UV confocal system). The
> pyrene is excitable at 345nm and emits at 380nm. We did some trials with
> straight dye and found we can excite it quite well in the 740-780nm
> range. Turns out that is where mitochondria light up too due to the
> large amounts of NADH they have. Very nice staining, who needs
> mitotracker.
>
> Does anyone have any secrets on how to get around this?
>
> Cheers
>
> Cam
>
>
> Cameron J. Nowell
> Microscopy Manager
> Centre for Advanced Microscopy
> Ludwig Institute for Cancer Research Melbourne - Parkville Branch
> PO Box 2008
> Royal Melbourne Hospital
> Victoria, 3050
> AUSTRALIA
> Office: +61 3 9341 3158
> Mobile: +61 422882700
> Fax: +61 3 9341 3104
> Facility Website
> Linked In Profile
>
>
>
>
>
> This communication is intended only for the named recipient and may
> contain information that is confidential, legally privileged or subject to
> copyright; the Ludwig Institute for Cancer Research Ltd does not waive any
> rights if you have received this communication in error.
> The views expressed in this communication are those of the sender and do
> not necessarily reflect the views of the Ludwig Institute for Cancer
> Research Ltd.
>
|
|
|